Bush MA - Search Results

1

Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes.

Matthews JE, Stewart MW, De Boever EH, Dobbins RL, Hodge RJ, Walker SE, Holland MC, Bush MA; Albiglutide Study Group. Matthews JE, et al. Among authors: bush ma. J Clin Endocrinol Metab. 2008 Dec;93(12):4810-7. doi: 10.1210/jc.2008-1518. Epub 2008 Sep 23. J Clin Endocrinol Metab. 2008. PMID: 18812476 Clinical Trial.

2

Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects.

Bush MA, Matthews JE, De Boever EH, Dobbins RL, Hodge RJ, Walker SE, Holland MC, Gutierrez M, Stewart MW. Bush MA, et al. Diabetes Obes Metab. 2009 May;11(5):498-505. doi: 10.1111/j.1463-1326.2008.00992.x. Epub 2008 Feb 11. Diabetes Obes Metab. 2009. PMID: 19187286 Clinical Trial.

3

Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing.

Rosenstock J, Reusch J, Bush M, Yang F, Stewart M; Albiglutide Study Group. Rosenstock J, et al. Diabetes Care. 2009 Oct;32(10):1880-6. doi: 10.2337/dc09-0366. Epub 2009 Jul 10. Diabetes Care. 2009. PMID: 19592625 Free PMC article. Clinical Trial.

4

A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus.

Seino Y, Inagaki N, Miyahara H, Okuda I, Bush M, Ye J, Holland MC, Johnson S, Lewis E, Nakajima H. Seino Y, et al. Curr Med Res Opin. 2014 Jun;30(6):1095-106. doi: 10.1185/03007995.2014.896327. Epub 2014 Mar 11. Curr Med Res Opin. 2014. PMID: 24552155 Clinical Trial.

5

Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus.

Seino Y, Nakajima H, Miyahara H, Kurita T, Bush MA, Yang F, Stewart MW. Seino Y, et al. Among authors: bush ma. Curr Med Res Opin. 2009 Dec;25(12):3049-57. doi: 10.1185/03007990903372999. Curr Med Res Opin. 2009. PMID: 19863477 Clinical Trial.

6

Effects of multiple doses of albiglutide on the pharmacokinetics, pharmacodynamics, and safety of digoxin, warfarin, or a low-dose oral contraceptive.

Bush M, Scott R, Watanalumlerd P, Zhi H, Lewis E. Bush M, et al. Postgrad Med. 2012 Nov;124(6):55-72. doi: 10.3810/pgm.2012.11.2613. Postgrad Med. 2012. PMID: 23322139 Clinical Trial.

7

Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.

Nunez DJ, Bush MA, Collins DA, McMullen SL, Gillmor D, Apseloff G, Atiee G, Corsino L, Morrow L, Feldman PL. Nunez DJ, et al. Among authors: bush ma. PLoS One. 2014 Apr 3;9(4):e92494. doi: 10.1371/journal.pone.0092494. eCollection 2014. PLoS One. 2014. PMID: 24699248 Free PMC article. Clinical Trial.

8

Multiple-dose safety, pharmacokinetics, and pharmacodynamics of the μ-opioid receptor inverse agonist GSK1521498.

Nathan PJ, Bush MA, Tao WX, Koch A, Davies KM, Maltby K, O'Neill BV, Napolitano A, Skeggs AL, Brooke AC, Richards DB, Williams PM, Bullmore ET. Nathan PJ, et al. Among authors: bush ma. J Clin Pharmacol. 2012 Oct;52(10):1456-67. doi: 10.1177/0091270011421785. Epub 2011 Dec 12. J Clin Pharmacol. 2012. PMID: 22162534 Clinical Trial.

9

Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy.

Marachelian A, Desai A, Balis F, Katzenstein H, Qayed M, Armstrong M, Neville KA, Cohn SL, Bush M, Gunawan R, Lim AP, Smith MA, Smith LM. Marachelian A, et al. Among authors: bush m. Cancer Chemother Pharmacol. 2016 Feb;77(2):405-12. doi: 10.1007/s00280-015-2955-9. Epub 2016 Jan 20. Cancer Chemother Pharmacol. 2016. PMID: 26791869 Free PMC article. Clinical Trial.

10

Effect of Food Intake and Body Position on the Pharmacokinetics of Swallowed APT-1011, a Fluticasone Orally Disintegrating Tablet, in Healthy Adult Volunteers.

Comer GM, Bush MA, Dellon ES, Marino MT. Comer GM, et al. Among authors: bush ma. J Clin Pharmacol. 2020 Jun;60(6):734-743. doi: 10.1002/jcph.1572. Epub 2020 Jan 15. J Clin Pharmacol. 2020. PMID: 31943257 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page